Cefdinir Powder, For Suspension
Product Images NDC 68788-4106

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 68788-4106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Aa8c2254 7124 437a B691 010c18c8c80e 126 1)

FDA Label Image

Cefdinir (B32b7bfb 4770 4da0 8c48 684233cd10c9 01)

FDA Label Image

Cefdinir For Oral Suspension Usp 250mg Per5ml (B32b7bfb 4770 4da0 8c48 684233cd10c9 03)

Cefdinir For Oral Suspension Usp 250mg Per5ml (B32b7bfb 4770 4da0 8c48 684233cd10c9 03)
This is information about Cefdinir for Oral Suspension, USP, in a concentration of 250mg/5mL, which is a generic version of Omnicef. The package includes directions for reconstitution and usage, as well as storage instructions. It is important to shake well before use and keep the container tightly closed. The product is manufactured by Lupin Limited. This text also includes warnings about the transfer of the medication to others and emphasizes keeping all drugs out of the reach of children. There are details about the expiration date, lot number, and batch number.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.